Ashwini Kurshan

The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern

M. Malim, C. Graham, K. Doores, 2022, medRxiv.

Omicron breakthrough infections in vaccinated or previously infected hamsters

P. McKay, R. Shattock, T. Peacock, 2022, bioRxiv.

Distinct antigenic properties of the SARS-CoV-2 Omicron lineages BA.4 and BA.5

M. Malim, E. Thomson, B. Charleston, 2022, bioRxiv.

Endogenous antibody responses in REGN-COV2-treated SARS-CoV-2-infected individuals

C. Graham, K. Doores, J. Edgeworth, 2023, Oxford open immunology.

Broad and potent neutralizing mAbs are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection

M. Malim, C. Graham, K. Doores, 2023, bioRxiv.

Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders

M. Malim, C. Harrison, D. Mclornan, 2022, Blood Advances.

Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection

M. Malim, J. Fox, C. Graham, 2023, mBio.